Petrus Trust Bets $16M on LKQ Amid Earnings Slump and Strategic Uncertainty

What happened

Petrus Trust acquired 520,000 LKQ shares in Q4 2025, increasing its position by $15.7 million as the stock traded down 31% from previous highs. This investment comes against a backdrop of declining fundamentals, with FY2025 Segment EBITDA falling to $1,509 million from $1,687 million due to lower repairable claims and tariff-induced margin pressure in North America. LKQ's board has initiated a comprehensive strategic review, including a potential sale, but has provided no timetable or interim updates, heightening investor uncertainty over timing. The market narrative has shifted to focus on strategic alternatives, yet operational challenges persist, with Specialty segment impairments and ongoing volume declines. While Petrus Trust's bet may signal confidence in a value-unlock transaction, it does not address the core need for evidence of earnings stabilization or clear progress in the strategic process.

Implication

First, the $16 million position indicates that some investors are willing to bet on LKQ's potential sale or restructuring, seeing current prices as attractive for event-driven returns. Second, however, this does not change the operational reality of declining North America volumes and margin compression from tariffs and competition. Third, the strategic review's lack of a definitive timeline creates 'clock risk,' where prolonged uncertainty could further pressure the stock if operations don't improve. Fourth, investors should remain cautious, as the master report recommends waiting for proof of free cash flow stability within the $700-850M range and North America organic growth turning positive. Fifth, until there are tangible milestones in the strategic process or operational recovery, the investment case for LKQ remains speculative and best approached with a WAIT stance.

Thesis delta

The Petrus Trust investment does not shift the investment thesis; LKQ still requires observable evidence of North America volume stabilization and maintained FCF guidance to warrant a buy. It reinforces that while external bets may provide short-term sentiment boosts, the fundamental risks from operational headwinds and strategic uncertainty persist, keeping the rating at WAIT.